Share-based Compensation (Tables)

12 Months Ended

Dec. 31, 2024

Share-Based Payment Arrangement [Abstract]

Schedule of Company's Restricted Stock Activity

A summary of INNOVATE’s restricted stock and restricted stock unit activity (as adjusted for the Reverse Stock Split) is as follows:

	Number of Shares	Weighted Average Grant Date Fair Value
Unvested - December 31, 2022	114,180	$	25.60
Granted	50,696	$	25.70
Vested	(102,304)	$	23.20
Unvested - December 31, 2023	62,572	$	29.48
Granted	367,681	$	6.15
Vested	(135,590)	$	12.64
Unvested - December 31, 2024	294,663	$	8.12

Schedule of Company's Stock Option Activity

A summary of INNOVATE’s stock option activity (as adjusted for the Reverse Stock Split) is as follows:

	Number of Stock Options	Weighted Average Exercise Price
Outstanding - December 31, 2022	499,515	$	50.20
Expired	(35,233)	$	31.20
Outstanding and exercisable- December 31, 2023	464,282	$	51.68
Granted	200,000	$	14.61
Expired	(446,549)	$	52.02
Outstanding - December 31, 2024	217,733	$	16.94
Exercisable - December 31, 2024	117,733	$	27.74

Schedule of Stock Option Valuation Assumptions

The fair value of each option award was determined on the date of grant using the Black-Scholes option-pricing model using the following assumptions:

	Year Ended December 31, 2024
Stock price at date of grant	$	6.27
Expected term	5.1 years - 5.6 years
Risk-free interest rate	4.1		%
Expected volatility	80.9% - 82.7%
Expected dividend yield	—		%
Grant date fair value per option	$2.67 - $4.75